4.7 Letter

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

Related references

Note: Only part of the references are listed.
Letter Hematology

ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

Animesh D. Pardanani et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

Article Hematology

Targeted deep sequencing in primary myelofibrosis

Ayalew Tefferi et al.

BLOOD ADVANCES (2016)

Article Hematology

ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia

Michelle A. Elliott et al.

AMERICAN JOURNAL OF HEMATOLOGY (2015)

Article Immunology

Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo

Omar Abdel-Wahab et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Oncology

Mutations and prognosis in primary myelofibrosis

A. M. Vannucchi et al.

LEUKEMIA (2013)

Article Hematology

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value

Marta Pratcorona et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)

Article Oncology

Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes

Felicitas Thol et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Medicine, General & Internal

Clinical Effect of Point Mutations in Myelodysplastic Syndromes

Rafael Bejar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)